ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2600

Signs of Immune Activation and Local Inflammation Are Present in the Bronchial Tissue of Patients with Untreated Early Rheumatoid Arthritis

Gudrun Reynisdottir1,2, Helga Olsen3, Vijay Joshua4, Marianne Engström2, Magnus Skold3, Anders Eklund5, Johan Grunewald3 and Anca I Catrina2, 1Rheumatology Unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, 2Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 3Department of Medicine, Division of Respiratory Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, 4Unit of Rheumatology, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 5Division of Respiratory Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Anti-CCP antibodies and rheumatoid arthritis (RA), Lung Disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Events in the lungs might contribute to generation of anti citrullinated protein antibodies (ACPA) in rheumatoid arthritis (RA). We investigated if signs of immune activation are present in the bronchial biopsies and bronchoalveolar lavage (BAL) of early-untreated RA patients in the absence of concomitant lung pathology.

Methods: 24 RA patients with symptom duration less than one year and naïve to disease-modifying antirheumatic drugs (DMARD) were subjected to bronchoscopy where bronchoalveolar lavage (BAL) and mucosal large bronchial biopsies were retrieved. For comparison 15 bronchial biopsies and 79 BAL samples from healthy volunteers were available. Histological examination was performed to evaluate lymphocyte infiltration, presence of immune cells (T and B cells, plasma cells, dendritic cells and macrophages) and immune activation markers. Cells composition of BAL samples was analyzed by differential counting and flow cytometry. 

Results:

Lymphocyte infiltration was more frequently found in ACPA-positive patients (9 out of 18 patients, 50%) as compared to ACPA-negative patients (1 our of 6, 17%, p>0.05) and controls (2 out of 15, 13%, p<0.05). Occasional formation of germinal center like structures was observed only in ACPA-positive RA patients (2 out of 18, 11%). These structures were positive for B cells markers and activation-induced cytidine deiminase and stained positively with biotinylated cit-enolase.

B cells and plasma cells were only found in ACPA-positive patients, while T cells were more frequently detected in bronchial biopsies of ACPA-positive (median 2, range 1-3) as compared to ACPA-negative (median 1, range 1-3) RA patients. Similar, expression of immune activation markers was higher in ACPA-positive as compared to ACPA-negative RA patients for both HLA-DR (median of 3, range 2-3 as compared to a median of 2, range 1-3, p<0.05) and HLA-DQ (median of 2, range 0-3 as compared to a median of 1, range 1-3, p<0.05). BAL samples of ACPA-positive but not ACPA-negative RA patients had significantly higher relative numbers of lymphocytes and expressed higher levels of activation markers compared to controls.

Conclusion:

Signs of immune cell accumulation and activation are present in the bronchial tissue of untreated early-RA patients without concomitant lung pathology, strengthening the role of the lung compartment as a critical initiating factor in the development of ACPA-positive RA.


Disclosure: G. Reynisdottir, None; H. Olsen, None; V. Joshua, None; M. Engström, None; M. Skold, None; A. Eklund, None; J. Grunewald, None; A. I. Catrina, None.

To cite this abstract in AMA style:

Reynisdottir G, Olsen H, Joshua V, Engström M, Skold M, Eklund A, Grunewald J, Catrina AI. Signs of Immune Activation and Local Inflammation Are Present in the Bronchial Tissue of Patients with Untreated Early Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/signs-of-immune-activation-and-local-inflammation-are-present-in-the-bronchial-tissue-of-patients-with-untreated-early-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/signs-of-immune-activation-and-local-inflammation-are-present-in-the-bronchial-tissue-of-patients-with-untreated-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology